IDegLira for type 2 diabetes: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IDegLira for type 2 diabetes: a systematic review and meta-analysis

Published:2023-09-28 Issue: Volume: Page:
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Liu Yang,Li Xuejing,Zheng Yingying,Wang Xiaoli,Wang Xianying

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-023-03543-z.pdf

Reference33 articles.

1. H. Sun, P. Saeedi, S. Karuranga et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022)

2. M.K. Ali, K.M. Bullard, J.B. Saaddine, C.C. Cowie, G. Imperatore, E.W. Gregg, Achievement of goals in U.S. diabetes care, 1999–2010. N. Engl. J. Med. 368(17), 1613–1624 (2013)

3. K.J. Lipska, X. Yao, J. Herrin et al. Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013. Diabetes Care 40(4), 468–475 (2017)

4. American Diabetes Association Professional Practice Committee, 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022. Diabetes Care 45(Suppl 1), S125–S143 (2022)

5. W. Wang, B.F.R. Agner, B. Luo et al. DUAL I China: Improved glycemic control with IDegLira versus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral antidiabetic drugs. J. Diabetes 14(6), 401–413 (2022)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of liraglutide in pediatric obesity: A review of clinical trial data;Obesity Medicine;2024-06

2. Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2024-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3